Search research articles
Contact Us
Filters
Showing results (331-340 of 377) with videos related to
Page
of 38
Sort By:
The Lancet. Rheumatology
|
January 24, 2026
Patient partnership model in rare and complex rheumatological conditions: research and beyond in European Reference Network ReCONNET
Jeanette Andersen, Rosaria Talaric, Diana Marinello, et al.
Journal of Translational Autoimmunity
|
January 1, 2024
Long-term outcomes of COVID-19 vaccination in patients with rare and complex connective tissue diseases: The ERN-ReCONNET VACCINATE study
Chiara Tani, Chiara Cardelli, Roberto Depascale, et al.
RMD Open
|
December 20, 2018
Systemic lupus erythematosus: state of the art on clinical practice guidelines
Farah Tamirou, Laurent Arnaud, Rosaria Talarico, et al.
RMD Open
|
November 8, 2018
Systemic sclerosis: state of the art on clinical practice guidelines
Vanessa Smith, Carlo Alberto Scirè, Rosaria Talarico, et al.
Scientific Reports
|
October 13, 2025
Factors influencing the choice of non-biologic versus biologic immunosuppressive therapy in systemic lupus erythematosus
Alessandra Bortoluzzi, Antonio Marangoni, Ettore Silvagni, et al.
Journal of Autoimmunity
|
October 2, 2021
Durable renal response and safety with add-on belimumab in patients with lupus nephritis in real-life setting (BeRLiSS-LN). Results from a large, nationwide, multicentric cohort
Mariele Gatto, Francesca Saccon, Laura Andreoli, et al.
Frontiers in Pharmacology
|
April 20, 2019
Long-Term Retention Rate of Anakinra in Adult Onset Still's Disease and Predictive Factors for Treatment Response
Antonio Vitale, Giulio Cavalli, Serena Colafrancesco, et al.
Frontiers in Pharmacology
|
November 9, 2016
A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study
Antonio Vitale, Antonella Insalaco, Paolo Sfriso, et al.
Frontiers in Pharmacology
|
June 30, 2017
Response to Interleukin-1 Inhibitors in 140 Italian Patients with Adult-Onset Still's Disease: A Multicentre Retrospective Observational Study
Serena Colafrancesco, Roberta Priori, Guido Valesini, et al.
The Lancet. Rheumatology
|
May 26, 2025
ERN ReCONNET-SLICC-SLEuro expert consensus on the therapeutic management of rare systemic lupus erythematosus manifestations
Laurent Arnaud, Guillermo Ruiz-Irastorza, Cynthia Aranow, et al.
Page
of 38
Search research articles
Search
Showing results (331-340 of 377) with videos related to
Sort By:
Page
of 38
The Lancet. Rheumatology
|
January 24, 2026
Patient partnership model in rare and complex rheumatological conditions: research and beyond in European Reference Network ReCONNET
Jeanette Andersen, Rosaria Talaric, Diana Marinello, et al.
Journal of Translational Autoimmunity
|
January 1, 2024
Long-term outcomes of COVID-19 vaccination in patients with rare and complex connective tissue diseases: The ERN-ReCONNET VACCINATE study
Chiara Tani, Chiara Cardelli, Roberto Depascale, et al.
RMD Open
|
December 20, 2018
Systemic lupus erythematosus: state of the art on clinical practice guidelines
Farah Tamirou, Laurent Arnaud, Rosaria Talarico, et al.
RMD Open
|
November 8, 2018
Systemic sclerosis: state of the art on clinical practice guidelines
Vanessa Smith, Carlo Alberto Scirè, Rosaria Talarico, et al.
Scientific Reports
|
October 13, 2025
Factors influencing the choice of non-biologic versus biologic immunosuppressive therapy in systemic lupus erythematosus
Alessandra Bortoluzzi, Antonio Marangoni, Ettore Silvagni, et al.
Journal of Autoimmunity
|
October 2, 2021
Durable renal response and safety with add-on belimumab in patients with lupus nephritis in real-life setting (BeRLiSS-LN). Results from a large, nationwide, multicentric cohort
Mariele Gatto, Francesca Saccon, Laura Andreoli, et al.
Frontiers in Pharmacology
|
April 20, 2019
Long-Term Retention Rate of Anakinra in Adult Onset Still's Disease and Predictive Factors for Treatment Response
Antonio Vitale, Giulio Cavalli, Serena Colafrancesco, et al.
Frontiers in Pharmacology
|
November 9, 2016
A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study
Antonio Vitale, Antonella Insalaco, Paolo Sfriso, et al.
Frontiers in Pharmacology
|
June 30, 2017
Response to Interleukin-1 Inhibitors in 140 Italian Patients with Adult-Onset Still's Disease: A Multicentre Retrospective Observational Study
Serena Colafrancesco, Roberta Priori, Guido Valesini, et al.
The Lancet. Rheumatology
|
May 26, 2025
ERN ReCONNET-SLICC-SLEuro expert consensus on the therapeutic management of rare systemic lupus erythematosus manifestations
Laurent Arnaud, Guillermo Ruiz-Irastorza, Cynthia Aranow, et al.
Page
of 38